Simulation-driven design of stabilized SARS-CoV-2 spike S2 immunogens

• Published in: Nature communications Vol. 15; no. 1; pp. 7370 - 15
• Main Authors: Nuqui, Xandra, Casalino, Lorenzo, Zhou, Ling, Shehata, Mohamed, Wang, Albert, Tse, Alexandra L., Ojha, Anupam A., Kearns, Fiona L., Rosenfeld, Mia A., Miller, Emily Happy, Acreman, Cory M., Ahn, Surl-Hee, Chandran, Kartik, McLellan, Jason S., Amaro, Rommie E.
• Format: Journal Article
• Language: English
• Published: London Nature Publishing Group UK 27-08-2024; Nature Publishing Group; Nature Portfolio
• Subjects: 101/28; 119/118; 147/28; 631/114/469; 631/250/590; 631/535/1258/1259; 631/57/2266; 639/638/563/981; Animals; Antibodies, Neutralizing - immunology; Antibodies, Viral - immunology; Conserved sequence; COVID-19; COVID-19 - immunology; COVID-19 - prevention & control; COVID-19 - virology; COVID-19 vaccines; COVID-19 Vaccines - immunology; Cryoelectron Microscopy; Design; Humanities and Social Sciences; Humans; Immunogenicity; Molecular Dynamics Simulation; multidisciplinary; Protein Stability; Protein structure; SARS-CoV-2 - genetics; SARS-CoV-2 - immunology; Science; Science (multidisciplinary); Severe acute respiratory syndrome coronavirus 2; Simulation; Spike Glycoprotein, Coronavirus - chemistry; Spike Glycoprotein, Coronavirus - genetics; Spike Glycoprotein, Coronavirus - immunology; Spike Glycoprotein, Coronavirus - metabolism; Structural analysis; Thermal stability; Tryptophan; Vaccine efficacy; Vaccines
• ISSN: 2041-1723; 2041-1723
• DOI: 10.1038/s41467-024-50976-9

The full-length prefusion-stabilized SARS-CoV-2 spike (S) is the principal antigen of COVID-19 vaccines. Vaccine efficacy has been impacted by emerging variants of concern that accumulate most of the sequence modifications in the immunodominant S1 subunit. S2, in contrast, is the most evolutionarily conserved region of the spike and can elicit broadly neutralizing and protective antibodies. Yet, S2’s usage as an alternative vaccine strategy is hampered by its general instability. Here, we use a simulation-driven approach to design S2-only immunogens stabilized in a closed prefusion conformation. Molecular simulations provide a mechanistic characterization of the S2 trimer’s opening, informing the design of tryptophan substitutions that impart kinetic and thermodynamic stabilization. Structural characterization via cryo-EM shows the molecular basis of S2 stabilization in the closed prefusion conformation. Informed by molecular simulations and corroborated by experiments, we report an engineered S2 immunogen that exhibits increased protein expression, superior thermostability, and preserved immunogenicity against sarbecoviruses.
The evolutionarily conserved SARS-CoV-2 spike’s S2 subunit provides the foundation for its usage as an immunogen in vaccines. Here, the authors use a simulation-driven approach to design S2-only immunogens stabilized in the closed prefusion conformation.